Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,342,139 |
|
|||||
| News | - | ||||||
| Day High | 396.98 | Low High |
|||||
| Day Low | 391.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -2.40 | -0.61% | 391.08 | 19:57:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 394.72 | 391.25 | 396.98 | 394.28 | 393.48 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 31,123 | 1,342,139 | $ 394.47 | $ 529,437,504 | - | 316.43 - 448.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:42:23 | 2 | $ 394.00 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 101.85B | 258.31M | - | 9.92B | 3.57B | 13.82 | 28.52 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 396.57 | 402.4869 | 391.01 | 395.28 | 1,019,890 | -5.49 | -1.38% |
| 1 Month | 417.75 | 421.45 | 391.01 | 405.63 | 909,851 | -26.67 | -6.38% |
| 3 Months | 431.03 | 448.40 | 391.01 | 418.52 | 1,208,505 | -39.95 | -9.27% |
| 6 Months | 367.55 | 448.40 | 341.90 | 400.16 | 1,335,710 | 23.53 | 6.40% |
| 1 Year | 326.52 | 448.40 | 316.43 | 375.33 | 1,230,697 | 64.56 | 19.77% |
| 3 Years | 220.86 | 448.40 | 176.36 | 280.32 | 1,510,534 | 170.22 | 77.07% |
| 5 Years | 167.79 | 448.40 | 164.07 | 257.87 | 1,543,664 | 223.29 | 133.08% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
